Skip to main content
FARMCITY SA logo

FARMCITY SA — Investor Relations & Filings

ISIN · AR0766650987 BYMA Wholesale and retail trade
Open in API
Filings indexed 52 across all filing types
Latest filing 2026-04-28 Capital/Financing Update
Country AR Argentina
Listing BYMA

About FARMCITY SA

https://www.farmacity.com/

FARMCITY SA is a retail company established in 1997, specializing in health, beauty, and wellness. It operates an extensive network of physical stores and an online platform, offering a comprehensive range of products. The company's core offerings include prescription and over-the-counter pharmaceuticals, dermocosmetics, skincare, cosmetics, personal care items, hair care, sun protection, dietary supplements, fragrances, baby products, home essentials, and healthy food. FARMCITY SA aims to provide diverse products and services across multiple categories to enhance customer well-being.

Recent filings

Filing Released Lang Actions
2 - PROGRAMA: PROGRAMA ONS POR HASTA USD100.000 - PROSPECTOS DE PROGRAMA GLOBAL O SERIES INDIVIDUALES
Capital/Financing Update Classification · 82% confidence The document is a full prospectus (“Prospecto de Programa”) for a debt issuance program (simple negotiable obligations) up to US$100 million, detailing terms, conditions, guarantees, legal framework, and CNV authorization. This is not an AGM material, earnings release, or regular annual/interim report, nor is it simply a publication announcement or regulatory certification. It constitutes a detailed financing document related to the company’s capital‐raising program. Under our taxonomy, such debt issuance prospectuses fall under Capital/Financing Update (CAP).
2026-04-28 Spanish
INFORMACIÓN RELEVANTE RELATIVA A INSTRUMENTOS - INFORME DE CALIFICACIÓN DE LA EMISORA - FARMCITY - HECHO RELEVANTE
Regulatory Filings Classification · 88% confidence The document is a standalone credit rating report (“Informe de Calificación”) issued by Moody’s Local Argentina, containing the issuer’s public rating, outlook, credit strengths and weaknesses, and detailed analysis. It is not an annual or interim financial report, earnings release, management discussion, regulatory announcement of a meeting, or any other specified category. There is no designated category for credit rating opinions in the taxonomy, so this falls into the fallback “Regulatory Filings (RNS)” category.
2026-04-28 Spanish
NORMA CONTABLE: NIIF - TIPO BALANCE: CONSOLIDADO - PERIODICIDAD: 1 - FECHA CIERRE: 2025-12-31 - ESTADOS CONTABLES - NIIF
Annual Report Classification · 96% confidence The document is a full set of consolidated financial statements for the year ended December 31, 2025, including income statement, balance sheet, cash flows, notes, auditor’s report, and the accompanying management narrative (Memoria). This constitutes the company’s complete annual report rather than a mere announcement or standalone audit report. FY 2025
2026-04-18 Spanish
- CÓDIGO DE GOBIERNO SOCIETARIO.
Governance Information Classification · 98% confidence The document is a detailed ‘Reporte del Código de Gobierno Corporativo’ for Farmacity S.A., describing corporate governance concepts, board functions, principles, structure, committees, and applicable regulations. It is not an AGM presentation, earnings release, financing update, proxy or voting announcement, nor a regulatory filing certifying a report. Instead, it provides an in-depth outline of the company’s internal governance rules and practices. This matches the definition of Governance Information (CGR).
2026-04-18 Spanish
FEC. CELEB.: 09-04-2026 - TEMA: 5 - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Management Reports Classification · 95% confidence The document is titled 'ACTA DE DIRECTORIO Nº 345' and is a detailed record of a board meeting held on March 9, 2026, by Farmacity S.A. It discusses the approval of the consolidated and separate financial statements for the fiscal year ended December 31, 2025, including the balance sheet, income statement, cash flow statement, notes, and the management report (Memoria). It also includes the report on corporate governance and the independent auditors' report. The document contains extensive narrative on the macroeconomic context, corporate profile, and board composition, indicating it is a comprehensive management report and financial statement approval record. This is not a mere announcement or certification but contains substantive financial and management information. Therefore, it fits best as a Management Reports (MDA) filing, which includes management's detailed explanation of financial results, business trends, and outlook. The document is not an Annual Report (10-K) because it is a board meeting minutes document approving the financials rather than the full annual report itself. It is not an Audit Report (AR) because it includes more than just audit information. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains the full text of the meeting and detailed management discussion. Confidence is high given the detailed content and nature of the document.
2026-04-18 Spanish
NORMA CONTABLE: NIIF - TIPO BALANCE: INDIVIDUAL - PERIODICIDAD: 1 - FECHA CIERRE: 2025-12-31 - ESTADOS CONTABLES - NIIF
Annual Report Classification · 95% confidence The document is the full set of annual financial statements (“Estados Financieros Separados”) for the fiscal year ended December 31, 2025, including the balance sheet, income statement, statement of cash flows, notes, the auditor’s report, and the management “Memoria.” This comprises a complete yearly report covering company activity and full financial performance, matching the Annual Report definition (10-K). FY 2025
2026-04-18 Spanish

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.